Insilico Medicine Included in Hong Kong Stock Exchange Tech 100 Index, AI Industry Opportunities Gain Attention
September 3, 2026 — 11:35 CST
This Data Is Locked!
This area is available only to Subscribers.
Insilico Medicine, a clinical-stage drug development technology company driven by generative artificial intelligence (AI), has announced its inclusion in the Hong Kong Stock Exchange Tech... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
